Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Opus Genetics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 46 | 1 | 43 | −2 |
| Shares | 14.6M | 16.6K | 17.5M | +2.96M (+20.3%) |
| Value | $14.7M | $16.3K | $16.5M | +$1.81M (+12.4%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Opus Genetics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 127,844 | $120.4K | 0.00% |
| Two Sigma Investments, LP | 40,190 | $37.9K | 0.00% |
| Financial Gravity Companies, Inc. | 16,555 | $15.6K | 0.00% |
| James Investment Research Inc | 16,364 | $15.4K | 0.00% |
| GWM Advisors LLC | 16,364 | $15.4K | 0.00% |
| XTX Topco Ltd | 15,808 | $14.9K | 0.00% |
| Tower Research Capital LLC (TRC) | 6,698 | $6.31K | 0.00% |
Sold out (9)
Institutions that held Opus Genetics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| AWM Investment Company, Inc. | 524,245 | $514.7K |
| Citadel Advisors LLC | 67,877 | $66.6K |
| Trust Co of Toledo NA | 30,963 | $30.4K |
| Apollon Wealth Management, LLC | 28,089 | $27.6K |
| HRT Financial LP | 15,168 | $14.0K |
| Warberg Asset Management LLC | 10,000 | $9.82K |
| Simplex Trading, LLC | 1,618 | $1.00K |
| Eastern Bank | 1,000 | $982 |
| JPMorgan Chase & Co | 58 | $57 |
Not filed for Q2 2025 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sofos Investments, Inc. | 16,555 | $16.3K |